实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (4): 464-467.doi: 10.3969/j.issn.1672-5069.2021.04.003

• 自身免疫性肝炎 • 上一篇    下一篇

自身免疫性肝炎患者维生素D缺乏调查及其临床特征分析*

梁玉萍, 粟全球, 张慧, 王佳林   

  1. 010017 呼和浩特市 内蒙古自治区人民医院消化内科
  • 收稿日期:2021-02-22 发布日期:2021-07-13
  • 通讯作者: 王佳林,E-mail:724192097@qq.com
  • 作者简介:梁玉萍,女,35岁,硕士研究生,主治医师
  • 基金资助:
    *内蒙古自治区自然科学基金资助项目(编号:2018LH08013)

Serum vitamin D deficiency in patients with autoimmune hepatitis

Liang Yuping, Su Quanqiu, Zhang Hui, et al   

  1. Department of Gastroenterology, Provincial People's Hospital, Huhhot 010017, Inner Mongolia Autonomous Region, China
  • Received:2021-02-22 Published:2021-07-13

摘要: 目的 了解自身免疫性肝炎(AIH)患者维生素D缺乏及其临床变化特征。方法 2015年1月~2020年11月我院诊治的AIH患者74例,使用美国Roche E-602全自动免疫分析仪及其配套试剂检测血清25-羟基维生素D。结果 在74例AIH患者中,发现血清维生素D严重缺乏20例,缺乏28例和正常26例;严重缺乏组年龄为(34.2±14.8)岁,显著小于缺乏组【(40.2±11.4)岁】或正常组【(47.2±10.8)岁,P<0.05】,男性占比为45.0%,显著高于缺乏组的21.4%或正常组的11.5%(P<0.05),血清白蛋白水平为(28.4±4.0)g/L,显著低于缺乏组的(32.0±3.8)g/L或正常组的(38.3±3.7)g/L(P<0.05),肝硬化占比为40.0%,显著高于缺乏组的21.4%或正常组的(15.4%),差异具有统计学意义(P<0.05),对治疗应答率为30.0%,显著低于缺乏组的46.4%或正常组的(73.1%),差异具有统计学意义(P<0.05),肝脏相关事件发生率为(65.0%),显著高于缺乏组的39.3%或正常组的19.2%(P<0.05);血清25-羟基维生素D缺乏组与正常组之间确诊年龄、性别比、血清白蛋白水平、肝硬化和肝脏相关事件发生率也具有显著性统计学差异(P<0.05);肝组织炎症活动G4级患者血清25-羟基维生素D水平为(19.3±6.2)nmol/L,显著低于G3级【(45.1±17.6)nmol/L】、G2级【(63.9±21.5)nmol/L】、G1级【(74.0±26.8)nmol/L】或G0级【(83.8±30.2)nmol/L,P<0.05】,肝纤维化F4期患者血清25-羟基维生素D水平为(23.1±7.8)nmol/L,显著低于F3期【(42.9±18.8)nmol/L】、F2期【(68.0±20.4)nmol/L】、F1期【(82.7±28.6)nmol/L】或F0期【(94.4±33.0)nmol/L,P<0.05】。结论 AIH患者可能存在严重的血清维生素D缺乏,其与病情严重和对治疗不应答有关,值得深入开展广泛的临床研究,以改善AIH患者预后。

关键词: 自身免疫性肝炎, 维生素D缺乏, 临床意义

Abstract: Objective The aim of this study was to investigate serum vitamin D deficiency in patients with autoimmune hepatitis (AIH). Methods A total of 74 patients with AIH were admitted to our hospital between January 2015 and November 2020, and all patients went liver biopsies. Serum 25-hydroxyvitamin D levels were detected. Severe vitamin D deficiency was defined as serum 25-hydroxyvitamin D level <25 nmol/L, life support D deficiency (deficiency) was defined as serum 25-hydroxyvitamin D level between 25nmol/L and 75nmol/L, and normal serum vitamin D level as >75nmol/L. Results Out of the 74 patients with AIH, severe vitamin D deficiency, deficiency and normal vitamin D levels were found in 20 cases, 28 cases and 26 cases; the age when diagnosed in patients with severe vitamin D deficiency was (34.2±14.8) year-old, significantly younger than [(40.2±11.4) year-old] in patients with vitamin D deficiency or [(47.2±10.8) year-old] in AIH patients with normal vitamin D levels (P<0.05), the percentage of males was 45.0%, significantly higher than 21.4% in deficiency patients or 11.5% in patients with normal vitamin D level (P<0.05), serum albumin level was (28.4±4.0) g/l, significantly lower than (32.0±3.8) g/l in patients with serum vitamin D deficiency or (38.3±3.7) g/l in patients with normal serum vitamin D level (P<0.05), the percentage of liver cirrhosis was 40.0%, which was significantly higher than (21.4%) in patients with serum vitamin D deficiency or (15.4%) in patients with normal serum vitamin D level (P < 0.05), the complete response to immunosuppressive therapy was 30.0%, which was significantly lower than 46.4% in patients with serum vitamin D deficiency or 73.1% in patients with normal serum vitamin D level (P < 0.05), the incidence of liver related events was 65.0%, which was significantly higher than 39.3% in patients with serum vitamin D deficiency or 19.2% in patients with normal serum vitamin D level (P<0.05), and there were significant differences as respect to ages at diagnosis, gender percentage, serum albumin levels, liver cirrhosis percentages and liver related events between patients with vitamin D deficiency and those with normal vitamin D levels (P < 0.05); serum 25-hydroxyvitamin D level in patients with G4 hepatic histological activity was (19.3±6.2)nmol/L, significantly lower than (45.1±17.6)nmol/L in patients with G3, or (63.9±21.5)nmol/L in with G2, or (74.0±26.8)nmol/L in with G1 or (83.8±30.2)nmol/L in with G0 (all P<0.05】, and serum 25-hydroxyvitamin D level in patients with F4 liver fibrosis was(23.1±7.8)nmol/L, significantly lower than (42.9±18.8)nmol/L in patients with F3, or (68.0±20.4)nmol/L in with F2, or (82.7±28.6)nmol/L in with F1 or (94.4±33.0)nmol/L in with F0 (all P<0.05). Conclusion Severe vitamin D deficiency is found in patients with AIH, which might be related to a severe disease and poor response to immunosuppressive treatment, and warrants further clinical investigation.

Key words: Autoimmune hepatitis, Vitamin D deficiency, Clinical implication